Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information

INTRODUCTION: Clinical trials in Alzheimer's disease are aimed at early stages of disease, including preclinical Alzheimer's disease. The high cost and time required to screen large numbers of participants for Aβ pathology impede the development of novel drugs. This study's objective...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimers Dement (Amst)
Main Authors: Insel, Philip S., Palmqvist, Sebastian, Mackin, R. Scott, Nosheny, Rachel L., Hansson, Oskar, Weiner, Michael W., Mattsson, Niklas
Format: Artigo
Language:Inglês
Published: Elsevier 2016
Subjects:
Cognitive & Behavioral Assessment
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045949/
https://ncbi.nlm.nih.gov/pubmed/27722193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2016.07.002
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items